Shortcuts 2020 2018 2017 2016 2014 2013
2020
-
BioTuesdays
BioCardia developing autologous and allogenic cardiovascular cell therapies Read More -
Pharmaceutical Technology
BioCardia’s novel CardiAMP stem cell therapy closer to approval in heart failure Read More -
The Big Biz show
The Big Biz Show interviews BioCardia CEO, Peter Altman Read More -
HealthCare Weekly
5 Innovations That Will Change the Treatment of Heart Disease Read More
2018
-
Cardiology Today
Ongoing trial assessing novel assay to determine response to cardiac regenerative therapy Read More -
University of Minnesota
Investigational Therapy Exploring Treatment of Heart Failure Seeks to Stimulate Body’s Natural Healing Response Read More -
BioWorld Med Tech
Biocardia wins IDE for cell therapy as treatment for angina Read More
2017
-
BioWorld Med Tech
Biocardia presses on with Cardiamp pivotal trial to treat patients with heart failure Read More -
Med Latest
BioCardia® Helix Results in Higher Stem Cell Retention in Myocardium Read More -
Fox 47
UW Health trial involves injecting stem cells into patients with heart failure Read More -
Medical press
First participant treated in trial of stem-cell therapy for heart failure Read More -
Cardiology today
First patient treated in trial of novel cell therapy Read More -
News Center Watch
Johns Hopkins, MSCRF, BioCardia treat first patient with CardiAMP in ischemic heart failure trial Read More -
Drug Delivery
BioCardia, Johns Hopkins treats first patient with CardiAmp cell therapy in Phase III trial Read More -
The Baltimore Sun
Patient's own bone marrow used to treat heart failure Read More
2016
-
Drug Delivery
BioCardia launches pivotal trial for CardiAmp heart failure treatment Read More -
Cardiac Interventions
Studies Presented for BioCardia’s CardiAMP Cell Therapy Read More
2014
-
Cardiology today
Clinical trial will explore bone marrow-derived cell therapy for HF Read More -
FDA NEWS
FDA OKs Phase III Trial of Cell-Based Heart Failure Therapy and Diagnostic Read More
2013
-
DAIC
Phase II TAC-HFT Trial Suggests Efficacy for Transendocardial Delivery of Autologous Cells for Ischemic Heart Failure Read More
News


Pharmaceutical Technology



Cardiology Today

University of Minnesota
press releases
CALL US NOW
EMAIL US NOW